Thursday, March 28, 2024
Advertisement
Tags Monopoly pricing

Tag: monopoly pricing

US prisoners sue for constitutional right to lifesaving Hep C cure

Attorneys filed lawsuits in Pennsylvania and Massachusetts this week on behalf of prisoners who say they’re being denied new lifesaving treatment for Hepatitis C because of the cost of the drugs. Gilead Sciences manufactures two versions of the cure, Harvoni and Sovaldi. Abbvie Pharmaceutical Limited, formerly Abbot Labs, manufactures another, Viekira Pak. The cost of any one of the three is roughly $90,000.